The objective of this study was to analyse incidence and mortality cancer trends in the Italian Network of Cancer Registries (about 8 000 000 inhabitants) during the period 1986-1997. Included were 525 645 newly diagnosed cancers and 269 902 cancer deaths (subjects > 14 years). Joinpoints (points in time where trend significantly changes from linearity) were found and estimated annual percentage changes (EAPC) used to summarize tendencies. Overall cancer incidence increased in both sexes and cancer mortality significantly decreased (since 1991 among men). Lung cancer showed significantly decreasing incidence (EAPC = -1.4%) and mortality (EAPC = -1.6%) among men and increasing trends among women. In women, breast cancer incidence significantly increased (EAPC = + 1.7%) and mortality decreased since 1989 (EAPC = -2.0%). Stomach cancer incidence and mortality decreased in both sexes. Prostate incidence sharply increased since 1991 and mortality decreased. Colon cancer incidence increased and rectum mortality decreased significantly in both sexes. Significant increases in incidence were also found for kidney (up to 1991 among men), urinary bladder, skin epithelioma, melanoma, liver (up to 1993 among men), pancreas, mesothelioma, Kaposi's sarcoma (up to 1995 among men), testis, thyroid, non-Hodgkin's lymphomas and multiple myeloma. Mortality significantly decreased for cancers of the oral cavity and pharynx, oesophagus, liver (women), larynx (men), bone, cervix (since 1990), central nervous system, urinary bladder, thyroid, Hodgkin's lymphomas and leukaemias (men). Non-Hodgkin's lymphoma mortality increased in both sexes. In conclusion, most of the changes seen can be explained as the effect of changes in smoking habits and of the extension of secondary prevention activities. The Italian health care system will also have to cope with growing cancer diagnostic and therapeutic needs due to population ageing.
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Introduction
Monitoring of cancer incidence and mortality trends is crucial for evaluating changes in population lifestyle, environmental risks and health care effectiveness.
Reports showing significant recent changes in cancer incidence and mortality trends have been published in North America (Weir et al., 2003;  http://seer.cancer.gov/; http://www.cancercare.on.ca) and in some western countries (Quinn et al., 2001; Van Dijck et al., 2002; Levi et al., 2003) . The epidemiology of some relevant cancer sites is changing due to modification of risk factor exposure, such as for lung and other smoking-related cancers, but also due to the diffusion of early diagnosis activity [e.g. prostate specific antigen (PSA) testing for prostate cancer] or organized screening programmes (Quinn, 2003) . Moreover, progression in therapy have contributed to decreasing mortality for some cancers (e.g. testis) (Classen et al., 2003) and breast neoplasms (Collaborative Group on Hormonal Factors in Breast Cancer, 1997).
Cancer registration started in Italy during the late 1970s relying on local registries; now more than 13 000 000 inhabitants, almost a quarter of the overall Italian population, live in areas where a cancer registry is active (Zanetti et al., 2002) . The Network of the Italian Cancer Registries (AIRT) has already published incidence, mortality and survival reports (Zanetti et al., 1997; Rosso et al., 2001; Zanetti et al., 2002) .
The aim of the present paper was to analyse incidence and mortality cancer trends from mid-1980s to late-1990s in the Italian areas where AIRT registries are active.
Materials and methods
The AIRT (www.registri-tumori.it) database collects data from 19 general registries, from three childhood cancer registries and from a colorectal cancer specialized one. For the present study we considered general registries only. These covered small/medium-sized areas corresponding to 31% of residents in northern regions, 32% in central and only 7% of resident in southern regions, with an overall average percentage of 23%. The mean death certificate only (DCO) proportion during 1993-1998 was 2.3% among males and 2.7% among females and the proportion of cases with histological verification was 79.1 and 81.1%, respectively (Zanetti et al., 2002) .
The registries had different lengths of activity between 1976 and 1998 (Zanetti et al., 2002) . As only a few of them were active before 1986 and a few others had already produced incidence data for 1998 we restricted the analysed period to 1986-1997 and included only those registries that were active for the whole period (six registries), or for at least 10 years (three registries). Since entry to the study in different calendar years or early exit before 1997 of cancer registries at different incidence levels could bias the general trend for the registries pool, we estimated the missing data (maximum 2 years) for the three registries with incomplete observations. Predicted incident cases were obtained from their own observed data. To take into account the observed trend, we carried out a preliminary joinpoint analysis, a model in which the trend is constrained to be linear but a varying linear trend is allowed over the study time if a significant change is detected. A 'joinpoint' is a point in time where lines with significantly different slopes/trend are connected together (Kim et al., 2000) . The best fitting model among models with a minimum of 0 and a maximum of 2 joinpoints, giving three different trends over the study period, was selected to estimate the missing data (http:// srab.cancer.gov/joinpoint/). Separate Poisson models were fitted for each sex and cancer site with the calendar year (continuous) and the 5-year age-group (categorical) as regressor variables.
The nine registries included in the analysis corresponded in 1997 to a population of about 8 000 000 inhabitants, 21% residing in the north, 19% in the central Italian regions and 2% in the southern Italian regions. In comparison with the total Italian population, the analysed population had an almost equal male/female ratio (0.93 AIRT versus 0.94 Italy) and was older; the proportion of the population older than 65 years was 18% in Italy and 20% in the AIRT region.
Mortality data for the same study period and geographic area were retrieved from the National Institute of Statistics (ISTAT) where all the Italian death certificates are collected, coded and analysed.
Only cases and deaths in the adult population (15 years and older) are analysed in the present report.
Incidence and mortality rates for the first and the last 3year period, 1986-1988 and 1995-1997, were computed, by means of the SEER*Stat software, for sex and cancer site and age-adjusted on the European standard population by means of the direct standard method (European adjusted rates).
Sex-and site-specific time trends, on the AIRT pool, were analysed by means of joinpoint analysis. For each model, the trend is summarized as estimated annual percentage change (EAPC), computed using a weighted least squares regression of the logarithm of each yearly adjusted rate; significant testing of EAPC to 0 was also computed. The joinpoint analysis was performed with the joinpoint 2.7 software provided by the National Cancer Institute (http://srab.cancer.gov/joinpoint/).
Results
In the area of the Italian Network of Cancer Registries, overall cancer incidence (525 645 cases) significantly increased from 1986 to 1997 in both sexes (men EAPC = + 1.1, women EAPC = + 1.5), and cancer mortality (269 902 cancer deaths) significantly decreased in men (since 1991 EAPC = -2.4) and in women (EAPC = -1.2) ( Fig. 1 ).
In Tables 1 and 2 the mean annual number of cases and deaths for the period 1995-1997 and the average standardized rates at the beginning and at the end of the analysed period (1986-1988 and 1995-1997) are shown; moreover, site-and sex-specific joinpoint analyses for the whole period, 1986-1997, are also reported.
Lung cancer, the most frequent cancer among males showed opposite trends in men and women. In fact, incidence decreased significantly among men (EAPC = -1.4) and increased among women (EAPC = + 1.2), and mortality decreased significantly among men (EAPC = -1.6) and increased among women (EAPC = + 0.9).
As regards the other smoking-related cancers, incidence of oral cavity and pharynx (among males) decreased significantly as did mortality in both sexes. Also for larynx cancer, incidence and mortality decreased; the decrease was significant only among men.
Female breast cancer incidence increased significantly from 1986 to 1997 (EAPC = + 1.7) with mortality that was increasing up to 1989 (EAPC = + 3.1), then decreased significantly (EAPC = -2.0). The incidence of prostate cancer showed an increasing tendency from 1986 to 1991 (EAPC = + 0.9) when the increase became sharp and statistically significant (EAPC = + 12.1); in 1994 the trend reduced its slope but it was still increasing significantly (EAPC = + 4.4). Mortality rates for prostate cancer were decreasing significantly (EAPC = -0.9) without any evident joinpoint during the analysed period.
Testis cancer incidence increased significantly (EAPC = + 1.7), with decreasing mortality.
Among the other main relevant cancer sites, colon incidence increased both in men (EAPC = + 2.5) and in women (EAPC = + 0.9), while rectal cancer had a stable incidence and significantly decreasing mortality.
For stomach cancer, incidence and mortality both decreased significantly in both sexes. Also oesophageal cancer showed decreasing incidence (not significant among females) and mortality trends in both sexes.
Liver cancer showed a significant increase in incidence rates in both sexes, but among males it changed its trend in 1993; mortality was significantly decreasing among females.
Skin melanoma and skin epithelioma tumours showed a sharply significant increasing incidence trend in both sexes with an EAPC of about 6%.
Among urinary system tumours, kidney cancer stopped its statistically significant increasing trend in 1991, only among men. The incidence rate of urinary bladder cancer increased significantly at about + 2% per year in both sexes, with significantly decreasing mortality.
Thyroid cancer was among those cancers that increased at the highest rate (EAPC = + 3.4 in men, and + 4.6 in 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 Year Standardized (European population) rates × 100,000
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Among lymphomas, there were opposite incidence trends in Hodgkin's (decreasing in both sexes) and non-Hodgkin's lymphoma (significantly increasing) and mortality also showed a striking reduction for Hodgkin's (men -9.1%, P < 0.001, females -7.1%, P = 0.008) and significant increasing trend for non-Hodgkin's lymphoma. The incidence of myeloma increased significantly in both sexes. Mortality for leukaemia decreased in both sexes (significantly among men).
Among other relevant cancer sites, pancreas cancer incidence increased significantly among men and women and mortality almost statistically significantly increased in both sexes (EAPC for men = + 0.8, P = 0.051, women + 0.8, P = 0.061).
Among cancers of the female genital organs, cervix uteri slowed down the reduction in incidence which, since 1990, was no longer significant. On the other hand cervical cancer mortality increased up to 1990 (EAPC = + 11.7%, P = 0.03), then it changed its trend (EAPC = -6.4% P = 0.004).
Among females, gallbladder cancer incidence decreased significantly. Bone cancers showed significant decreasing mortality in both sexes, as did cancers of the central nervous system (CNS). Kaposi's sarcoma increased among men up to 1995 (EAPC = + 13.0), but then reversed its trend, while it was still increasing among women.
Mesothelioma incidence showed significantly increasing trends in both sexes.
Discussion
The main result of the present study was the evidence of a significant reduction in cancer mortality among both women and men, the latter since 1991. A decreasing incidence trend may explain part of the overall mortality decrease, as for stomach cancer, and for oral cavity, larynx and lung cancer among men. Mortality trends for highly fatal cancers (e.g. lung cancer) are strictly comparable to incidence, reflecting the lack of important progress in therapy.
For other cancer sites the decrease in mortality seen may be due to improved treatment, as documented elsewhere for cancers of the rectum (Colorectal Cancer Collaborative Group, 2001), female breast (Collaborative Group on Hormonal Factors in Breast Cancer, 1997), cervix uteri (Green et al., 2001) and leukemias (Cheson et al., 1996) .
The diffusion of effective screening interventions or of early detection activities may have contributed to the observed mortality reduction for breast, cervix uteri, and possibly prostate cancer.
In the area of the Italian Network of Cancer Registries, although cancer mortality has decreased, the overall cancer incidence has increased, and the perceived increase has been, and will presumably be, still greater. In fact, due to the ageing of the population, while standardized rates increased in the adult population from 1986 to 1997 by 15-16%, crude rates were twice this rate (28.6%). Whether this increasing trend will continue or not is difficult to foresee because it was the consequence of many different trends; for instance, the increasing incidence trend for prostate cancer due to early diagnosis Cancer trends in Italy Crocetti et al. 291 Table 2 AIRT mortality cancer trends by site and sex. Age-adjusted (on the European standard population) mortality rates (AAR) for the periods 1986-1988 and 1995-1997 , average number of deaths during 1995-1997, joinpoint analysis for the period 1986-1997 with corresponding expected annual percentage change (EAPC)
Site deaths (1993 ) AAR 1986 -1988 AAR 1995 Annual average of cases 1995 Joinpoint analyses (1986 Trend will probably end in the next few years, but increasing trends may result from the introduction of other screening programmes, e.g. for large bowel cancer. Therefore, the public health burden and resources needed for the diagnosis and therapy of cancer are expected to increase in the future.
Risk factors
As regards lung and other smoking-related cancers, in agreement with recently published papers (Engeland, 1996; Myrdal et al., 2001; Quinn et al. 2001; Weir et al., 2003) , the opposite trends both in incidence and in mortality seen in men and women reflected different trends in smoking habits. Data from the National Institute of Statistics showed that the proportion of smokers (among subjects older than 14 years) was 71% among men in 1959 , 45.6 and 17.7% in 1983 for men and women, 37.8 and 17.8% in 1990 (Sistema Statistico Nazionale, 1993 , and 31.2% among men and 16.9% among women in 2001 (Sistema Statistico Nazionale, 2002) . The differences between the sexes are becoming smaller in younger subjects; in fact, in 2001 the proportion of smokers was 9.5% in men and 5.3% in women in the age group 14-17 years, and 24.3 and 17.1% in 15-18 year olds (Sistema Statistico Nazionale, 2002) .
Stomach cancer has very high incidence rates in some Italian areas (Parkin et al., 2002) . This cancer is showing a secular decreasing incidence trend, in agreement with other western countries (Menegoz et al., 1995; Levi et al., 1996; McKean-Cowdin et al., 2000; Quinn et al., 2001;  http://seer.cancer.gov/) that is probably due to changes in diet, including increased consumption of fresh fruit and vegetables and improvements in food preservation (Buiatti et al., 1989) . As regards dietary factors, high dietary fat and meat intake and low intake of fibre may have contributed to the increase in colon cancer incidence (Potter et al., 1993) .
Chronic infection with hepatitis B and C are major risk factors for liver cancer in developed countries. The availability of surrogate markers testing for non-A, non-B hepatitis since the mid-1980s, and of antibody to hepatitis C virus (HCV) since 1990, may have contributed to the diagnostic improvement and documented increase in incidence, as also evidenced in the US (Howe et al., 2001) .
Although alcohol consumption is declining in Italy, the proportion of alcohol drinkers, especially wine drinkers, is still high, 71.2% among men and 45.1% among women in 2000 (Sistema Statistico Nazionale, 2002) .
As evidenced in England and Wales, Scotland, US, and in Norway (Engeland, 1996 (Chow et al., 2000) , and the past use of phenacetin-based drugs (McCredie, 1994) may have been important.
The increasing incidence trends for mesothelioma are of interest not only because of occupational risks but also because of the possibility of environmental exposure (Magnani et al., 1991; Bilancia et al., 2003) .
The upward trend in the incidence of multiple myeloma documented in recent decades in the USA (Brown et al., 2001) may be related to the increased exposure to suspected carcinogens such as ionizing radiation, pesticides and benzene, but the effect of more sensitive diagnostic tools (McKean-Codwin et al., 2000) may also be relevant.
Among infectious factors, the acquired immune deficiency syndrome (AIDS) epidemic, starting in Italy during the late 1980s, has caused an increase in AIDS-related cancers. This may be true, at least in part, for non-Hodgkin's lymphomas (Franceschi et al., 1999) and multiple myelomas (Grulich et al., 1999) that may share such aetiology. Moreover, Kaposi's sarcoma also showed a striking increase in incidence that reversed its trend among men in more recent years (Rezza et al., 2000) . Data from the National AIDS Registry shows that the incidence of notified cases (proxy of infection) was increasing up to 1995; afterwards, there was a decreasing trend (http://www.iss.it/sanita/ registri/aids.htm).
Early diagnosis
The introduction of breast cancer screening has had the effect of raising the incidence in the target age groups, especially at the prevalence screening but also during subsequent ones. This has recently been documented in England (Quinn and Allen, 1995) and in the Netherlands (Van Dijck et al., 2002) . In the area included in the present study, mammography screening programmes were active in six out of nine registries during the analysed period. A survey carried out in Italy during 1999-2000 by the Italian National Institute of Statistics (http:// www.istat.it/Societ-/Sanita-e-p/) reported that 46.6% of women older than 40 years had had a mammograph once in their lives; these percentage rose to about 60% for those 55-64 years old. Also the decrease in mortality evidenced since 1989 may be related to earlier detection, although, as evidenced in other countries, the improved breast cancer care and/or the improved Cancer trends in Italy Crocetti et al. 293 care access may have been the major determinants (Botha et al., 2003) .
For prostate cancer, incidence curves showed the same shape as recently evidenced in some western countries (Quinn et al., 2001 ; http://seer.cancer.gov/), generally regarded as the consequence of the introduction of PSA testing. PSA was introduced in Italy at the beginning of the 1990s (Barchielli et al., 1999) and it is now largely used by general practitioners as a routine check-up examination. A survey carried out in 1999-2000 in a northern Italian area found that 34% of the male population older than 50 years, with no history of prostate cancer, had received a PSA test in the 2-year study period (Russo et al., 2002) ; these very high percentages were confirmed by another survey in central Italy in 2000 (Zappa et al., 2003) . The rate of incidence increase slowed down in the AIRT area since 1994, and, as found in Canada (http://www.cancercare.on.ca/preven-tion_622.htm), the US (http://seer.cancer.gov/), and England (Quinn et al., 2001) , a change in trend is to be expected in the next few years. The decrease in prostate mortality found in the present study is also intriguing for its possible relationship with PSA testing but results from ongoing US and European randomized clinical trials are needed before PSA efficacy can be inferred.
The sharp increase in skin melanoma is related to the diffusion of early diagnosis activity as documented by the sharp increase in 'thin' lesions, but it is also probably a result of a true increase -due to sunlight exposure (Devesa et al., 1995) -as documented by stable rates for 'thick' tumours (Crocetti and Carli, 2003) .
In conclusion, even if cancer mortality is decreasing, the overall cancer burden is increasing and the Italian health care system will have to cope with growing cancer diagnostic and therapeutic needs.
